4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004012
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 220,467 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | 2020-03-17 | Grant or award · Employee Stock Option (Right to Buy) | +168,776 | 168,776 | D | ||
| TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | 2020-03-17 | Grant or award · Restricted Stock Units | +51,691 | 51,691 | D | ||
Loading xslF345X03/edgar.xml…